In less than a week’s time, families around the country will be sitting down to tuck into their traditional Christmas dinner.
Lilly discloses its first biotech acquisition of the year, buying Morphic for $3.2B
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS